Search results
Sanofi sues Sarepta over US patents for gene therapy treatments - ET HealthWorld | Pharma
The Economic Times· 13 hours agoLondon: Sanofi-owned biotech company Genzyme has sued rival Sarepta Therapeutics in Delaware federal...
Sanofi India stock falls 2% on weak June quarter results; profit falls 16%
Business Standard India· 2 days agoThe fall in the share price came after the pharmaceutical company reported a weak set of June...
Sanofi lifts 2024 profit forecast on strength in Dupixent, new products - ET HealthWorld | Pharma
The Economic Times· 6 days agoLondon: Sanofi on Thursday raised its full-year profit outlook after strong demand for blockbuster...
Sanofi’s immunology bet starts to pay off
BioPharma Dive· 6 days agoSome analysts described Sanofi’s pipeline of immune system therapies, which includes more than half a dozen drugs in mid- to late-stage testing, as...
Sanofi India Q1 Results | Diabetes brands post double-digit sales growth, net profit slips 16% -...
CNBC TV18· 5 days agoPharmaceutical firm Sanofi India Ltd on Friday (July 26) reported a 16% year-on-year (YoY) decline...
Shifting Gears: Dr Reddy’s scaling up JVs, inorganic growth to add value, expand market reach
The Hindu· 59 minutes agoPharma major Dr Reddy’s Laboratories has been adding significant value to its business and future growth prospects by scaling up strategic collaborative deals and acquisitions in key therapeutic ...
Sanofi India Standalone June 2024 Net Sales at Rs 463.50 crore, down 34.36% Y-o-Y
CNBC Awaaz· 2 days agoJun'24Mar'24Jun'23Net Sales/Income from operations463.50732.40706.10Other Operating...
USFDA gives tentative nod to Lupin’s generic formulation to treat HIV infection
Financial Express· 2 hours agoGlobal pharma major Lupin Limited on Wednesday announced that it has received tentative approval...
Sanofi India Ltd spurts 1.9%, rises for fifth straight session
Business Standard India· 6 days agoSanofi India Ltd is quoting at Rs 6682, up 1.9% on the day as on 12:44 IST on the NSE. The stock is down 3.35% in last one year as compared to a 23.16% jump in NIFTY and a ...
GSK settles another heartburn drug lawsuit in Illinois - ET HealthWorld | Pharma
The Economic Times· 2 days agoFirst approved in 1983, Zantac, sold at different times by GSK, Pfizer , Sanofi and Boehringer...